This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022
Title: Jiujiu Zhou: Innovator in Cancer Treatment
Introduction
Jiujiu Zhou is a notable inventor based in Shanghai, China. He has made significant contributions to the field of medicinal chemistry, particularly in the development of cancer treatment options. His innovative work has led to the creation of a unique derivative of 5-fluorouracil, which has potential applications in treating various tumor diseases.
Latest Patents
Jiujiu Zhou holds 1 patent for his invention titled "5-fluorouracil derivatives, preparation methods and uses thereof." This patent discloses a 5-fluorouracil derivative characterized by a specific molecular structure. The derivative includes alkoxy groups and fluorine-substituted alkoxy groups, which are crucial for its effectiveness. The invention also outlines methods for preparing this derivative and its use in treating cancer and diseases caused by abnormal neovascularization in mammals.
Career Highlights
Throughout his career, Jiujiu Zhou has focused on advancing pharmaceutical innovations. His work has been instrumental in developing new therapeutic agents that can improve patient outcomes in oncology. His dedication to research and development has positioned him as a key figure in the field.
Collaborations
Jiujiu Zhou has collaborated with notable colleagues, including Xiaodong Yu and Zhikai Zhang. These partnerships have fostered a collaborative environment that enhances the research and development process.
Conclusion
Jiujiu Zhou's contributions to the field of cancer treatment through his innovative patent demonstrate his commitment to improving healthcare. His work continues to inspire advancements in medicinal chemistry and offers hope for effective cancer therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile